Search

Byline: Tobi Thomas Health and inequalities correspondent A combined flu and coronavirus vaccine brings about a higher immune response to both diseases than when the vaccines are administered separately, a [...]

Gilead Sciences, Inc. announced the company is advancing enrollment in two groundbreaking collaborative studies to evaluate the tolerability of an investigational long-acting HIV prevention option in groups of people in [...]

Two clinical trials have launched to examine a novel long-acting form of HIV pre-exposure prophylaxis (PrEP) in cisgender women and people who inject drugs. The mid-stage studies will assess the [...]

Gilead Sciences, Inc. and Merck, known as MSD outside of the United States and Canada, today announced results from the Phase 2 clinical study evaluating the investigational combination of islatravir, [...]

The life of a pet dog follows a predictable trajectory. Over time, the floppy-eared puppy that keeps falling asleep in his food bowl will become a lanky-legged adolescent with an [...]

2024 MAR 18 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- Investigators discuss new findings in Digestive System Diseases and Conditions - Crohn's Disease. According [...]

Byline: Ken Alltucker, USA TODAY The Food and Drug Administration on Thursday approved the drug lecanemab for people with early Alzheimer's disease, making it easier for older adults to get [...]

Byline: Laurie McGinley Jay Reinstein stood in the hospital hallway, gently bickering with his father about Larry David's misanthropic character on 'Curb Your Enthusiasm.' 'I don't like him. He's mean-spirited,' [...]

Byline: Laurie McGinley Jay Reinstein stood in the hospital hallway, gently bickering with his father about Larry David's misanthropic character on 'Curb Your Enthusiasm.' 'I don't like him. He's mean-spirited,' [...]

Byline: Ken Alltucker, USA TODAY Federal drug regulators will decide by July 6 whether to grant the first traditional approval to an amyloid-busting drug to treat Alzheimer's disease. On June [...]

Gilead Sciences, Inc. announced PURPOSE 5, the first Phase 2 clinical trial to evaluate an investigational long-acting HIV prevention option in Europe. The study will assess the persistencedefined as consistent [...]

The drug, which will be sold as Qalsody by the pharmaceutical company Biogen, targets a genetic cause of a devastating neurological illness. The Food and Drug Administration on Tuesday authorized [...]

Byline: Karen Weintraub, USA TODAY The Biden administration has announced a $5 billion program to accelerate the development of next-generation COVID-19 vaccines and treatments. Like Operation Warp Speed, which developed [...]

Union Minister of State (Independent Charge) Science & Technology; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr Jitendra Singh today said the National Biopharma Mission is supporting [...]

Byline: MATTHEW PERRONE; ASSOCIATED PRESS WASHINGTON -- U.S. health officials on Friday approved a closely watched Alzheimer's drug that modestly slows the brain-robbing disease, albeit with potential safety risks that [...]

Byline: Nada Hassanein, USA TODAY The Food and Drug Administration has approved Sunlenca, an injectable therapy to suppress HIV for patients who suffered drug resistance to other regimens. Experts say [...]

The drug, lecanemab, made by Eisai and Biogen, also carried risks of brain swelling and bleeding and should be studied further, a report of the findings said. The hotly anticipated [...]

Byline: Daniel Gilbert An experimental Alzheimer's drug moderately slowed the effects of the disease but was linked to patient safety risks that warrant longer clinical trials, according to a study [...]

Byline: Brian Hallenbeck Nov. 11--LEDYARD -- Given his fondness for the outdoors, Todd Fletcher, a Westerly man retired from the Air Force and from firefighting, considers himself fortunate to have [...]

Biogen and Eisai reported the finding from a large late-stage clinical trial of lecanemab, a drug they are developing. The pharmaceutical companies Biogen and Eisai said on Tuesday that a [...]

Byline: Laurie McGinley An experimental Alzheimer's drug slowed cognitive and functional decline by 27 percent in a closely watched clinical trial, the sponsors of the medication said Tuesday, increasing the [...]

2023 JUN 12 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Hansa Biopharma ('Hansa'), a pioneer in enzyme technology for rare immunological conditions, announced the first [...]

TOKYO and CAMBRIDGE, Eisai Co., Ltd. and Biogen Inc. announced that the results from Eisais large global Phase 3 confirmatory Clarity AD clinical study of lecanemab (development code: BAN2401), an [...]

Hong Kong has given the green light for clinical trials to begin on three new Covid-19 vaccines manufactured by mainland companies ahead of their expected launch across the border in [...]

Stemirna Therapeutics is ­preparing to launch a global multi-­site human trials of its Covid-19 vaccine soon as the firm pushes for the second Chinese-made shot based on mRNA ­technology to [...]